Impact Biomedical Inc. (NYSEAMERICAN:IBO) Stock Short Interest Drops 94.3%

Impact Biomedical Inc. (NYSEAMERICAN:IBO) saw a large drop in short interest in the month of September. As of September 30th, there was short interest totaling 30,169 shares, a drop of 94.3% from the September 15th total of 526,986 shares. Currently, 3.2% of the company’s shares are short sold. Based on an average daily trading volume, of 15,208 shares, the days-to-cover ratio is currently 2.0 days.

Impact Biomedical Stock Performance

Shares of NYSEAMERICAN:IBO traded up $0.14 during mid-day trading on Friday, hitting $4.25. The company had a trading volume of 4,014 shares, compared to its average volume of 14,890. Impact Biomedical has a one year low of $4.06 and a one year high of $10.47. The firm has a fifty day moving average price of $5.79 and a 200 day moving average price of $6.60.

Impact Biomedical (NYSEAMERICAN:IBO) last issued its earnings results on Friday, August 7th. The company reported ($0.13) earnings per share (EPS) for the quarter. Impact Biomedical had a return on equity of 8.81% and a net margin of 2,254.28%. The company had revenue of $0.00 million for the quarter.

About Impact Biomedical

Impact Biomedical, Inc is a biotechnology and life sciences company focused on developing and commercializing biomedical technologies, pharmaceutical products and related health solutions. Its activities have included research into antiviral, antimicrobial and anti-inflammatory applications, with an emphasis on technologies intended to address infectious diseases and other public health needs.

The company has described a portfolio of biomedical intellectual property and development programs rather than a broad portfolio of established commercial products.